ArticlePharmacology research & perspectives2014

The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profile.

Li-Fang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.